Pinz Capital Management, LP Incyte Corp Transaction History

Pinz Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $554,568 - $669,564	-8,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $532,056 - $622,524	8,400 New	8,400 $617,000
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $1.64 Million - $2.24 Million	-26,000 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $1.9 Million - $2.49 Million	26,000 New	26,000 $2.27 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.